has been a bilingual journal restricted to German and English. Within the last years, the number of articles written in English has increased considerably by the submission of more articles from English speaking countries, but even more so by the increasing use of English by investigators residing in Austria, Germany, Switzerland and many countries not having German or English as their mother tongue.
Beginning with this issue, all scientific material will be presented in English. The use of German will be restricted to information of particular interest to readers of the German speaking countries, e.g. announcements of scientific societies and reviews of haematological books edited in German.
For readers and authors from the German speaking countries, the editors should explain that the decision to accept manuscripts in English only was not easily made, but was the result of intensive discussion among the editors and with the publisher. They are fully aware of the fact, that the difficulties of preparing a manuscript are naturally greater if one has to express oneself in a language not one's own and they will continue to provide the help of a language editor for the final linguistic corrections. However, in the words of Peter Woodford "authors should neither worry to much about language difficulties nor use them as an excuse for failing to unravel tangled lines of thought".
The decision to publish all papers in English is more than a measure to survive in the multiplicity of international medical periodicals. It is the acknowledgement of the role English has played as a new "lingua franca" of biomedicine in promoting progress of medical, and especially haematological research.
For the Editors H. Heimpel
